Compare Medpace Holdings Inc (MEDP) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs United Airlines Holdings Inc — how do they compare? Medpace Holdings Inc trades at $534.03 (market cap $15.08B), while United Airlines Holdings Inc trades at $118.4 (market cap $38.15B). The key difference: United Airlines Holdings Inc is far larger — about 2.5× Medpace Holdings Inc's market cap. Which is the better fit depends on your goals.
| MEDP | UAL | |
|---|---|---|
Market Cap | $15.08B | $38.15B |
Sector | Technology | Industrials |
52-Week High | $620.59 | $136.11 |
52-Week Low | $308.88 | $84.57 |
Enterprise Value | $14.55B | $55.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
United Airlines (UAL) trades at $116.77, up 1.18% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with a P/E of 10.81 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth is robust, rising to $59.07B in 2025, though fuel costs pose headwinds. Analyst consensus is strongly bullish with a $163.75 price target and no sell ratings among 47 analysts.
Outlook remains positive due to resilient travel demand and premium revenue growth, but investors face risks from volatile fuel prices and operational disruptions. The stock offers value with low valuation multiples and upward earnings revisions, yet macroeconomic sensitivity requires caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
